Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001070047 | SCV001235255 | benign | not provided | 2023-10-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004030738 | SCV002754756 | uncertain significance | not specified | 2018-10-23 | criteria provided, single submitter | clinical testing | The p.W373C variant (also known as c.1119G>C), located in coding exon 2 of the KIAA2022 gene, results from a G to C substitution at nucleotide position 1119. The tryptophan at codon 373 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV001070047 | SCV004036621 | uncertain significance | not provided | 2023-03-22 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |